Associate Professor Jeremy Crook
Associate Professor and Principal Fellow at the Intelligent Polymer Research Institute (IPRI) and the Illawarra Health and Medical Research Institute, University of Wollongong.
Honorary Associate Professor Principal Fellow in the Department of Surgery, St Vincent’s Hospital, Melbourne
BSc (Honours), University of Tasmania, Australia.
PhD, The University of Melbourne (Department of Pathology), Australia.
Jeremy’s main current research interest is the use of human pluripotent and neural stem cells for disease modeling and ex vivo tissue engineering, which includes through collaboration cutting-edge technologies from materials engineering for improved cell culture and differentiation, early phase drug discovery, and regenerative medicine.
Jeremy obtained a PhD from The University of Melbourne (Department of Pathology) in 1998. He undertook his first post-doctoral appointment in 1999 as a Fogarty International Centre Medical Research Fellow at the US National Institutes of Health (NIH). Working under renowned researchers Drs Daniel Weinberger and Joel Kleinman in the Clinical Brain Disorders Branch of the National Institute of Mental Health, Jeremy was awarded the NIH “Fellows Award for Research Excellence” in 2001.
From 2002 - 2007, Jeremy was Project Manager (2002 - 2004) and Program Manager (2004 - 2007) of Platform Technologies for then Melbourne - followed by Singapore - based company ES Cell International (ESI). ESI specialized in the development of human stem cell-based therapies for the treatment of diabetes and congestive heart failure. In Nov 2007, ESI published the first report on the derivation of clinically-compliant pluripotent stem cells in Cell Stem Cell; highlighted in Nature Reports Stem Cells. Jeremy’s team oversaw the derivation of the clinical-lines, which were selected by the Californian Institute of Regenerative Medicine (CIRM) and University of California System (UC-system) institutions to streamline their efforts to translate pluripotent stem cells to human therapies.
Since working at ESI, Dr Crook has held a series of academic appointments including Group Leader in the A*STAR Institute of Medical Biology (IMB) in Singapore, where together with preeminent stem cell scientist Dr Alan Colman he established the Stem Cells Disease Modeling Laboratory. Jeremy's group at IMB was the first to use human stem cells to model neuropsychiatric disease (Nature press Molecular Psychiatry 2010).
In addition to Group Leader at IMB, Dr Crook concurrently held the position of Head of the Singapore Stem Cell Bank, which provided quality controlled GLP-grade stem cells in support of Singaporian and overseas stem cell R&D (In Vitro Cell Dev Biol - Animal 2010). Jeremy’s work in stem cell banking extends to his leading role with the International Stem Cell Banking Initiative (ISCBI; In Vitro Cell Dev Biol - Animal 2010), whose purpose is to help develop a global network of stem cell banks through support for existing banks and by encouraging the development of new banks in member countries.
Interested in the Bionics program? Contact Associate Professor Jeremy Crook